A guide to the use of interferon-alpha in the management of chronic myelogenous leukaemia

J Cortes, S O'Brien - BioDrugs, 2000 - Springer
Interferon-alpha (IFNα) can induce major cytogenetic responses in 30 to 40% of patients
with chronic myelogenous leukaemia (CML) and up to 50% when combined with cytarabine …
相关文章

A Guide to the Use of Interferon-Alpha in the Management of Chronic Myelogenous Leukaemia

J Cortes, S O'Brien - BioDrugs, 2000 - infona.pl
Interferon-alpha (IFNα) can induce major cytogenetic responses in 30 to 40% of patients
with chronic myelogenous leukaemia (CML) and up to 50% when combined with cytarabine …

A guide to the use of interferon-alpha in the management of chronic myelogenous leukaemia

J Cortes, S O'Brien - BioDrugs, 2000 - augusta.elsevierpure.com
Interferon-alpha (IFNα) can induce major cytogenetic responses in 30 to 40% of patients
with chronic myelogenous leukaemia (CML) and up to 50% when combined with cytarabine …

A guide to the use of interferon-alpha in the management of chronic myelogenous leukaemia

J Cortes, S O'Brien - BioDrugs, 2000 - mdanderson.elsevierpure.com
Interferon-alpha (IFNα) can induce major cytogenetic responses in 30 to 40% of patients
with chronic myelogenous leukaemia (CML) and up to 50% when combined with cytarabine …

A Guide to the Use of Interferon-Alpha in the Management of Chronic Myelogenous Leukaemia.

J Cortes, S O'Brien - BioDrugs, 2000 - search.ebscohost.com
Interferon-alpha (IFNα) can induce major cytogenetic responses in 30 to 40% of patients
with chronic myelogenous leukaemia (CML) and up to 50% when combined with cytarabine …

[引用][C] A Guide to the Use of Interferon-Alpha in the Management of Chronic Myelogenous Leukaemia

J Cortes, S O'Brien - BioDrugs, 2000 - Adis International